PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Leukemia Research0 citations

Clinical trial evidence + real world data: How do we ensure equal access to optimal CLL care

View Full Paper
MFMoritz FürstenauUniversity of CologneCNCarsten Utoft NiemannUniversity of Copenhagen

Key Points

  • Equal access to care is crucial for improving outcomes in chronic lymphocytic leukemia (CLL), and disparities exist.
  • Clinical trials often do not represent the general population, leading to gaps in real-world data.
  • Recommendations suggest integrating real world data with clinical trial findings to enhance patient care.
  • Addressing access disparities may enable more equitable treatment and better health outcomes for CLL patients.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fürstenau et al. (2026) studied this question.

synapsesocial.com/papers/69a76055c6e9836116a2cf86https://doi.org/10.1016/j.leukres.2026.108184
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A charter for improving care for people living with chronic lymphocytic leukemia: six principles for excellence2025 · 2 citations
  2. 2First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial2024 · 83 citations
  3. 3Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study2024 · 143 citations
  4. 4Integration Models for Delivering COVID-19 Vaccines Through HIV Services in Low-and Middle-Income Countries: A Scoping Review2025 · 1 citations
  5. 5Ensuring Ethical Postprogression Therapy for Patients in Randomized Trial Control Arms2023 · 13 citations